Based on the recent understanding of TOB1, a putative role of TOB1 may be associated with tumor suppressor SMAD4 and oncogenic CTNNB-mediated signaling, likely including SMAD4-mediated suppression of AURKA-CTNNB activation. The gene discussed is CTNNB1; the disease is neoplasm.